{"status":"OK","data":{"advertisement":{"id":244654,"title":"ZAPYTANIE OFERTOWE nr 36/2024/Z/KONGO","partial_offer_allowed":false,"publication_date":"2024-03-07","submission_deadline":"2024-03-15 23:59:59","planned_sign_date":"2024-03-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2024-03-07 14:44:27","modified_at":"2024-03-16 00:00:02","contact_persons":[{"id":368,"forename":"Anna","surname":"Za\u0142\u0119cka","phone_number":"","email":"anna.zalecka@celonpharma.com","created_by":null,"created_at":"2026-07-01 13:24:58","modified_at":"2026-07-01 13:24:58","modified_by":null}],"orders":[{"id":397151,"estimated_value":null,"order_items":[{"id":447892,"description":"Realizacja us\u0142ug badawczych, dotycz\u0105cych optymalizacji sekwencji rozwijanego humanizowanego przeciwcia\u0142a bispecyficznego w zakresie identyfikacji reszt lub ci\u0105g\u00f3w reszt aminokwasowych, kt\u00f3re potencjalnie mog\u0105 generowa\u0107 problemy z termostabilno\u015bci\u0105, rozpuszalno\u015bci\u0105, degradacj\u0105 i/lub tendencj\u0105 do agregacji przeciwcia\u0142a oraz zaproponowania zmian w sekwencji, prowadz\u0105cych do potencjalnej redukcji wy\u017cej wymienionych problem\u00f3w, jednocze\u015bnie utrzymuj\u0105c jak najwy\u017cszy wyj\u015bciowy poziom humanizacji oraz przygotowanie i dostarczenie ekspresyjnych konstrukt\u00f3w genetycznych koduj\u0105cych sekwencje w r\u00f3\u017cnych wariantach nios\u0105cych zaproponowane zmiany optymalizacyjne oraz opcjonalnie wyprodukowanie wybranych wariant\u00f3w optymalizacyjnych przeciwcia\u0142a.\n\nSzczeg\u00f3\u0142y w za\u0142\u0105czonym zapytaniu ofertowym. ","warranty_period":null,"cpv_items":[{"id":8512,"code":"73000000-2","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe oraz pokrewne us\u0142ugi doradcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"nowodworski","commune":"Czosn\u00f3w","locality":"Kazu\u0144 Nowy","created_by":null,"created_at":"2024-03-07 14:44:27","modified_at":"2024-03-07 14:44:27","modified_by":null,"id":501911,"type":{"id":1,"name":"adres"},"group_uuid":"c9aaf7f0-cc25-47ff-9e59-04a1edd10c3f"}],"participation_conditions":[],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2024-03-07 14:44:27","modified_at":"2024-03-07 14:44:27","modified_by":null,"group_uuid":"dd342f5a-1df8-4495-8b04-bea6f4cc2ea6"}],"evaluation_criteria":[{"id":682556,"price_criterion":true,"description":"Cena 100%","created_by":null,"created_at":"2024-03-07 14:44:27","modified_at":"2024-03-07 14:44:27","modified_by":null,"group_uuid":"ef8b023d-1cbe-4538-9b8c-7f9793e819b7"}],"is_variant":false,"title":"Us\u0142uga optymalizacji sekwencji przeciwcia\u0142a","order_node":{"id":301218},"created_by":null,"created_at":"2024-03-07 14:44:27","modified_at":"2024-03-07 14:44:27","modified_by":null}],"created_by":{"id":177,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Celon Pharma S.A.","identification_number_type":"nip","identification_number":"1181642061","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"warszawski zachodni","commune":"\u0141omianki","locality":"Kie\u0142pin","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":652459,"street":"Ogrodowa ","number_description":"2A","postcode":"05-092"},"created_by":{"id":177,"contact_persons":[]},"created_at":"2024-03-07 14:44:26","modified_at":"2024-03-07 14:44:26","modified_by":{"id":177,"contact_persons":[]},"id":245210},"advertisement":{"id":186097,"number":"2024-177-186097","publication_date":"2024-03-07","created_by":{"id":177,"contact_persons":[]},"created_at":"2024-03-07 14:44:26","modified_at":"2024-03-16 00:00:02","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[244654],"enrollment":null,"projects":[{"id":43069,"name":"Opracowanie pierwszego w klasie innowacyjnego immunokoniugatu o dzia\u0142aniu immunomoduluj\u0105cym i cytotoksycznym, jako kandydata na lek w terapii nowotwor\u00f3w","number":"A032/23","activity":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"region":null,"institution":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:27:55","modified_at":"2023-02-01 09:27:55","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"full_number":"FENG.01.01-IP.01-A032/23","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"type":"project","created_by":{"id":177,"contact_persons":[]},"created_at":"2023-12-06 11:00:15","modified_at":"2023-12-06 11:00:15","modified_by":{"id":177,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":244654,"publication_date":"2024-03-07"},"id":1260447,"name":"ZAPYTANIE OFERTOWE","file":{"id":1405248,"name":"ZO_36_2024_Z_KONGO.pdf","created_at":"2024-03-07 14:43:12","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1405248"},"group_uuid":"a2debf7c-95f0-4e2a-aac1-b1ad0c960643"},{"origin":{"id":244654,"publication_date":"2024-03-07"},"id":1260448,"name":"za\u0142. 1 - O\u015bwiadczenie o braku powi\u0105za\u0144","file":{"id":1405249,"name":"zal. 1 Oswiadczenie o braku powiazan FENG.pdf","created_at":"2024-03-07 14:43:25","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1405249"},"group_uuid":"f9162700-a862-4245-a993-243b2fd0f69f"},{"origin":{"id":244654,"publication_date":"2024-03-07"},"id":1260449,"name":"RfQ","file":{"id":1405250,"name":"RfQ 36_2024_Z_KONGO.pdf","created_at":"2024-03-07 14:43:38","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1405250"},"group_uuid":"bfafaa93-4730-49e9-b5fc-809eb7f00f58"},{"origin":{"id":244654,"publication_date":"2024-03-07"},"id":1260450,"name":"Att. 1 Statement","file":{"id":1405251,"name":"att. 1 Statement \u2014 FENG.pdf","created_at":"2024-03-07 14:43:51","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1405251"},"group_uuid":"a2342a06-7025-4e89-ae8f-31aeed1d38e0"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}